Budget 2026 research call: Study urges higher public health spending as medical costs rise and inequality deepens
An academic study released ahead of Budget 2026-27 argues India must raise public healthcare spending to reduce out-of-pocket burden and address widening access gaps. The research links long-term health expenditure trends to factors including income, inflation, education, urbanisation and life expectancy, and warns that under-investment leaves vulnerable households exposed to financial distress.
A new academic study released ahead of the Union Budget 2026-27 has revived calls for a stronger increase in India’s public healthcare spending, warning that rising medical costs and unequal access are placing a heavier burden on households—especially those with limited financial resilience.
The research examines multi-decade trends and argues that India’s health financing structure remains skewed: public investment is relatively limited while private expenditure and out-of-pocket payments continue to carry a large share of day-to-day healthcare costs. This imbalance, the study suggests, can translate into treatment delays, skipped care and financial stress for families facing serious illness.
By analysing long-run drivers of healthcare spending, the study links expenditure patterns to macro and social factors such as per capita income, inflation, urbanisation, life expectancy and education enrolment. The overall message is that as the economy and society change, healthcare costs do not simply rise uniformly; they also reshape who can access care, and at what price.
The paper argues that stronger public financing can reduce the direct cost pressure on individuals and make access more equitable. It highlights that without a sustained increase in government health spending, the burden of illness is most likely to fall on those least able to pay, particularly in rural areas and among economically weaker groups.
Industry voices quoted alongside the research said Budget 2026-27 is an opportunity to align health funding with India’s ambitions in advanced therapies, drug discovery, and innovation-driven care. They also pointed to policy levers such as insurance coverage for high-cost, potentially curative treatments, clearer regulation and targeted tax rationalisation for critical inputs.
With Budget day nearing, the study’s core recommendation is straightforward: to lower out-of-pocket exposure and improve health outcomes, India must back its healthcare goals with a larger, more consistent public spending commitment—supported by reforms that improve delivery and reduce disparities across regions.